Cargando…
Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis
SIMPLE SUMMARY: The association of obesity with a host of comorbidities and its role in cancer have been studied extensively, but its influence on cancer treatments is not well understood. In particular, little is known about the interplay between obesity and immune checkpoint inhibitor (ICI)-induce...
Autores principales: | Kono, Miho, Shatila, Malek, Xu, Guofan, Lu, Yang, Mathew, Antony, Mohajir, Wasay, Varatharajalu, Krishnavathana, Qiao, Wei, Thomas, Anusha S., Wang, Yinghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136922/ https://www.ncbi.nlm.nih.gov/pubmed/37190257 http://dx.doi.org/10.3390/cancers15082329 |
Ejemplares similares
-
Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis
por: Machado, Antonio Pizuorno, et al.
Publicado: (2023) -
Diarrhea and colitis related to immune checkpoint inhibitor and BRAF/MEK inhibitor therapy
por: Kuang, Andrew G., et al.
Publicado: (2023) -
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer
por: Liu, Cynthia, et al.
Publicado: (2023) -
Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors
por: Vasavada, Shaleen, et al.
Publicado: (2022) -
Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis
por: Saji, Alice, et al.
Publicado: (2022)